Abbott Laboratories (Abbott Laboratories) Interest Expense : USD-545 Mil (TTM As of Dec. 2023)

View and export this data going back to 1949. Start your Free Trial

What is Abbott Laboratories Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Abbott Laboratories's interest expense for the three months ended in Dec. 2023 was USD -159 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was USD-545 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Abbott Laboratories's Operating Income for the three months ended in Dec. 2023 was USD 1,780 Mil. Abbott Laboratories's Interest Expense for the three months ended in Dec. 2023 was USD -159 Mil. Abbott Laboratories's Interest Coverage for the quarter that ended in Dec. 2023 was 11.19. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Abbott Laboratories Interest Expense Historical Data

The historical data trend for Abbott Laboratories's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Interest Expense Chart

Abbott Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-670.00

-546.00

-533.00

-558.00

-637.00

Abbott Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-153.00	-159.00	-166.00	-159.00	-61.00

Abbott Laboratories Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was USD-545 Mil.

Abbott Laboratories (NYSE:ABT) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Abbott Laboratories's Interest Expense for the three months ended in Dec. 2023 was USD-159 Mil. Its Operating Income for the three months ended in Dec. 2023 was USD1,780 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was USD14,548 Mil.

Abbott Laboratories's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	1780	/	-159
	=	11.19

The higher the ratio, the stronger the company's financial strength is.

Abbott Laboratories (Abbott Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (NYSE:ABT) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

ABT:Mexico 0Q15:UK ABL:Germany ABL:Germany ABL:Germany ABL:Germany ABT:Chile ABT:Switzerland ABTT34:Brazil ABT:Austria ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Executives

Andrea F Wainer	officer: Executive Vice President	100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Daniel J Starks	director	ONE ST JUDE MEDICAL DRIVE, ST PAUL MN 55117
Mccoy John A. Jr.	officer: VICE PRESIDENT	C/O ABBOTT LABORATORIES, 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Michael F Roman	director	3M COMPANY OFFICE OF GENERAL COUNSEL, 3M CENTER, ST. PAUL MN 55144-1000
Patricia Paola Gonzalez	director	100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Louis H. Morrone	officer: EXECUTIVE VICE PRESIDENT	100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Philip P Boudreau	officer: Vice President	100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Michael O'grady	director	50 S LASALLE STREET, CHICAGO IL 60603
Gregory A Ahlberg	officer: Senior Vice President	100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Randel William Woodgrift	officer: Senior Vice President	100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
John F Ginascol	officer: Executive Vice President	100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Salvadori Daniel Gesua Sive	officer: Senior Vice President	100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064-6092
Mary K Moreland	officer: Executive Vice President	100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Lisa D Earnhardt	officer: Executive Vice President	1555 ADAMS DRIVE, C/O INTERSECT ENT, INC., MENLO PARK CA 94025
Robert E Funck	officer: Vice President, Controller	100 ABBOTT PARK ROAD, D-378, AP6D-2, ABBOTT PARK IL 60064-6092